BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28860188)

  • 1. Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation.
    Scannevin RH; Alexander R; Haarlander TM; Burke SL; Singer M; Huo C; Zhang YM; Maguire D; Spurlino J; Deckman I; Carroll KI; Lewandowski F; Devine E; Dzordzorme K; Tounge B; Milligan C; Bayoumy S; Williams R; Schalk-Hihi C; Leonard K; Jackson P; Todd M; Kuo LC; Rhodes KJ
    J Biol Chem; 2017 Oct; 292(43):17963-17974. PubMed ID: 28860188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
    Alford VM; Kamath A; Ren X; Kumar K; Gan Q; Awwa M; Tong M; Seeliger MA; Cao J; Ojima I; Sampson NS
    ACS Chem Biol; 2017 Nov; 12(11):2788-2803. PubMed ID: 28945333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
    Shoari A; Rasaee MJ; Kanavi MR; Daraei B
    J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
    Vandooren J; Van den Steen PE; Opdenakker G
    Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomolecular basis of matrix metallo proteinase-9 activity.
    Swetha R; Gayen C; Kumar D; Singh TD; Modi G; Singh SK
    Future Med Chem; 2018 May; 10(9):1093-1112. PubMed ID: 29676173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potent and specific inhibitors targeting the active site of MMP-9 from the engineered SPINK2 library.
    Yano H; Nishimiya D; Kawaguchi Y; Tamura M; Hashimoto R
    PLoS One; 2020; 15(12):e0244656. PubMed ID: 33373399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the hemopexin domain of matrix metalloproteinases in cell migration.
    Dufour A; Sampson NS; Zucker S; Cao J
    J Cell Physiol; 2008 Dec; 217(3):643-51. PubMed ID: 18636552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quest for selective MMP9 inhibitors: a computational approach.
    Shaikh AS; Sethi A; Makhal PN; Rathi B; Kaki VR
    J Biomol Struct Dyn; 2023; 41(24):15053-15066. PubMed ID: 36905674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
    Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
    Eur J Med Chem; 2020 May; 194():112260. PubMed ID: 32224379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.
    Gao Q; Wang Y; Hou J; Yao Q; Zhang J
    J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix.
    Han YP; Yan C; Zhou L; Qin L; Tsukamoto H
    J Biol Chem; 2007 Apr; 282(17):12928-39. PubMed ID: 17322299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
    Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
    Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of matrix metalloproteinase inhibitors by chemical arrays.
    Kawatani M; Fukushima Y; Kondoh Y; Honda K; Sekine T; Yamaguchi Y; Taniguchi N; Osada H
    Biosci Biotechnol Biochem; 2015; 79(10):1597-602. PubMed ID: 25988721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8.
    Morla S; Desai UR
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9.
    Dufour A; Sampson NS; Li J; Kuscu C; Rizzo RC; Deleon JL; Zhi J; Jaber N; Liu E; Zucker S; Cao J
    Cancer Res; 2011 Jul; 71(14):4977-88. PubMed ID: 21646471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
    Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2).
    Rosenblum G; Meroueh SO; Kleifeld O; Brown S; Singson SP; Fridman R; Mobashery S; Sagi I
    J Biol Chem; 2003 Jul; 278(29):27009-15. PubMed ID: 12679334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.
    Vandooren J; Born B; Solomonov I; Zajac E; Saldova R; Senske M; Ugarte-Berzal E; Martens E; Van den Steen PE; Van Damme J; Garcia-Pardo A; Froeyen M; Deryugina EI; Quigley JP; Moestrup SK; Rudd PM; Sagi I; Opdenakker G
    Biochem J; 2015 Jan; 465(2):259-70. PubMed ID: 25360794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the complex and dynamic process of activation of matrix metalloproteinases.
    Kotra LP; Cross JB; Shimura Y; Fridman R; Schlegel HB; Mobashery S
    J Am Chem Soc; 2001 Apr; 123(13):3108-13. PubMed ID: 11457021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-2 and -9 are activated in joint diseases.
    Clegg PD; Carter SD
    Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.